Bill Sponsor
House Bill 2273
115th Congress(2017-2018)
Charlotte's Web Medical Access Act of 2017
Introduced
Introduced
Introduced in House on May 1, 2017
Overview
Text
Introduced in House 
May 1, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 1, 2017)
May 1, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 2273 (Introduced-in-House)


115th CONGRESS
1st Session
H. R. 2273


To amend the Controlled Substances Act to exclude cannabidiol and cannabidiol-rich plants from the definition of marihuana, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

May 1, 2017

Mr. Perry (for himself, Ms. Norton, Mr. Calvert, Mr. Cooper, Mr. Cohen, Mr. Hunter, Mr. Sensenbrenner, Mr. Perlmutter, Mr. Stewart, Mr. Lowenthal, Mrs. Wagner, Mr. Grijalva, Mr. Wittman, Mr. David Scott of Georgia, Mr. O'Rourke, and Mr. Jones) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend the Controlled Substances Act to exclude cannabidiol and cannabidiol-rich plants from the definition of marihuana, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Charlotte’s Web Medical Access Act of 2017”.

SEC. 2. Exclusion of cannabidiol and cannabidiol-rich plants from definition of marihuana.

(a) In general.—Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended in paragraph (16)—

(1) by striking “(16) The” and inserting “(16)(A) The”; and

(2) by adding at the end the following:

“(B) Cannabidiol and cannabidiol-rich plants—

“(i) are excluded from the definition of marihuana under subparagraph (A); and

“(ii) shall not be treated as controlled substances under this Act.”.

(b) Definitions.—Section 102 of the Controlled Substances Act (21 U.S.C. 802), as amended, is further amended by adding at the end the following:

“(57) The term ‘cannabidiol-rich plant’ means the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.

“(58) The term ‘cannabidiol’ means the substance cannabidiol, as derived from a cannabidiol-rich plant.”.

SEC. 3. Other limitations.

(a) Non-Applicability of Federal Food, Drug, and Cosmetic Act.—The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) shall not apply to cannabidiol or cannabidiol-rich plants as those terms are defined in section 102 of the Controlled Substances Act (21 U.S.C. 802) as amended by this Act.

(b) State law.—Nothing in this Act shall prohibit or otherwise restrict any activities related to the use, production, or distribution of marijuana in a State in which such activities are legal under State law.

SEC. 4. Sense of Congress with respect to suspicious activity reports.

It is the sense of the Congress that, after the date of the enactment of this Act, a transaction should not be treated as a suspicious transaction for purposes of section 5318(g) of title 31, United States Code, solely because such transaction involved cannabidiol or a cannabidiol-rich plant.

SEC. 5. Sunset provision.

The provisions of this Act, and the provisions inserted into the Controlled Substances Act by this Act, shall cease to apply on the date that is 3 years after the date of enactment of this Act.